ESMO Immuno Oncology Congress 2017
You are still on time to register as Press representative for the ESMO Immuno Oncology Congress 2017 to be held in Geneva, 7-10 December 2017.
ESMO Media Releases
ESMO Celebrates Successful Completion of 3rd ESMO Asia Congress in Singapore
Since its inauguration in 2015, ESMO Asia Congress has garnered attention and significant interest from cancer experts and researchers not only in Asia but around the world. This year, the Congress is endorsed by twenty-one oncology societies across Asia and has attracted close to 3000 participants.
Study Shows New Second Line Therapy for Metastatic Colorectal Cancer is Effective and Safe
A randomised trial in 650 patients has confirmed the safety and efficacy of a new second line treatment for metastatic colorectal cancer, researchers report at the ESMO Asia 2017 Congress.
Osimertinib Improves Progression-free Survival in Asian EGFR-mutated Lung Cancer Patients
Osimertinib improves progression-free survival compared to standard first line therapy in Asian patients with EGFR-mutated non-small-cell lung cancer (NSCLC), according to the Asian subset analysis of the FLAURA trial presented at the ESMO Asia 2017 Congress, sumultaneously published in The New England Journal of Medicine.
Global Analysis Looks at Policy Gaps and How to Advance Breast Cancer Control in Asia
Education conducted by civil society can play an important role in filling breast cancer policy gaps and advancing cancer control, including advanced breast cancer, researchers report at the ESMO Asia 2017 Congress.
ALEX study shows alectinib 600 mg more effective than crizotinib in Asian lung cancer patients
A subanalysis of the phase III ALEX study has shown that alectinib 600 mg twice daily is more effective than standard of care crizotinib in Asian patients with anaplastic lymphoma kinase (ALK) positive non-small-cell lung cancer (NSCLC), researchers report at the ESMO Asia 2017 Congress.
Only one in five Indonesian Women are Aware of Cervical Cancer Screening
Just one in five Indonesian women are aware of cervical cancer screening, according to a study presented at the ESMO Asia 2017 Congress.
Study Finds All Myanmar Mouth Cancer Patients Chew Betel Quid
A study in Myanmar has found that all mouth cancer patients use smokeless tobacco, researchers report at the ESMO Asia 2017 Congress. Betel quid chewing often starts in adolescence and is associated with smoking and drinking alcohol, which are also risk factors for oral cancer.
Mainstreaming Genetic Counselling for Ovarian Cancer Could Support Screening, in Malaysia and Beyond
A study that looked at mainstreaming genetic counselling for ovarian cancer to support screening programmes in Malaysia was presented at the ESMO Asia 2017 Congress.
Study Analyses Mutations in Cerebrospinal Fluid in Lung Cancer with Brain Metastases
Researchers have explored the analysis of mutations in cerebrospinal fluid of lung cancer patients with brain metastases in a study presented at the ESMO Asia 2017 Congress.
Asia’s Cancer Experts Convene in Singapore at the ESMO Asia 2017 Congress
The European Society for Medical Oncology (ESMO) opened its 3rd ESMO Asia Congress today, once again in Singapore, attracting close to 3000 regional and international cancer doctors with leading researchers and experts to promote advances in science, diagnosis, treatment, and best practices for cancer patients in Asia
More Care is Needed for Cancer Supportive Care
ESMO Asia 2017 Congress reveals the psychosocial impact on cancer survivors in Asia and their unmet needs.